Humankind Investments LLC cut its position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 46.3% during the 2nd quarter, Holdings Channel reports. The firm owned 12,888 shares of the company’s stock after selling 11,111 shares during the period. Humankind Investments LLC’s holdings in Colgate-Palmolive were worth $1,172,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Cidel Asset Management Inc. increased its holdings in shares of Colgate-Palmolive by 13.6% in the second quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock valued at $29,912,000 after buying an additional 39,413 shares in the last quarter. Sequoia Financial Advisors LLC grew its holdings in shares of Colgate-Palmolive by 18.6% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 30,273 shares of the company’s stock worth $2,752,000 after acquiring an additional 4,738 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Colgate-Palmolive by 1.2% during the second quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock worth $7,522,129,000 after purchasing an additional 993,432 shares during the period. Welch Group LLC lifted its holdings in shares of Colgate-Palmolive by 1.5% during the second quarter. Welch Group LLC now owns 665,041 shares of the company’s stock valued at $60,452,000 after purchasing an additional 9,689 shares during the last quarter. Finally, Arista Wealth Management LLC acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $571,000. Institutional investors own 80.41% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on CL shares. The Goldman Sachs Group cut their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, October 2nd. Barclays cut their price target on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective for the company in a research note on Tuesday. Evercore ISI cut their target price on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating on the stock in a research note on Monday, November 3rd. Finally, Wells Fargo & Company reduced their target price on Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating for the company in a report on Monday, November 3rd. Ten equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $89.00.
Colgate-Palmolive Stock Up 1.4%
Colgate-Palmolive stock opened at $78.32 on Friday. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $100.18. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.60 and a current ratio of 0.93. The firm has a market cap of $63.13 billion, a PE ratio of 21.94, a P/E/G ratio of 5.50 and a beta of 0.30. The firm’s 50 day moving average price is $78.23 and its two-hundred day moving average price is $83.59.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.17 billion. During the same quarter last year, the business posted $0.91 EPS. The company’s revenue for the quarter was up 1.9% on a year-over-year basis. On average, research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be paid a $0.52 dividend. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. Colgate-Palmolive’s payout ratio is 58.26%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- MarketBeat Week in Review – 12/8 – 12/12
- Trading Halts Explained
- Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
- What Investors Need to Know to Beat the Market
- The Best Holiday Present You Can Give Yourself? Costco Stock
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
